参考文献/References:
[1] Siegel RL,Miller KD,Jemal A.Cancer statistics,2020[J].CA:A Cancer Journal for Clinicians,2020,70(1):7-30.
[2] 邸金娜,刘敬禹,张 莉.基于网络药理及分子对接技术对人参治疗非小细胞肺癌作用机制研究[J].陕西医学杂志,2021,50(6):669-672,677.
[3] Poncelet L,Dumont JE,Miot F,et al.The dual oxidase DUOX2 stabilized with DUOXA2 in an enzymatic complex at the surface of the cell produces extracellular H2O2 able to induce DNA damage in an inducible cellular model[J].Exp Cell Res,2019,384(1):111620.
[4] Sorapipatcharoen K,Tim-Aroon T,Mahachoklertwattana P,et al.DUOX2 variants are a frequent cause of congenital primary hypothyroidism in thai patients[J].Endocr Connect, 2020,9(11):1121-1134.
[5] 张 雪,韩 晶,周欣亮,等.DUOXA2在结直肠癌组织中表达及其与预后的关联[J].中华肿瘤防治杂志,2021,28(7):502-507.
[6] Oudkerk M,Liu S,Heuvelmans MA,et al.Lung cancer LDCT screening and mortality reduction - evidence,pitfalls and future perspectives[J].Nat Rev Clin Oncol,2021,18(3):135-151.
[7] 汪 莉,杜红旭,周正国,等.攻癌固真汤联合吉非替尼治疗肺癌气虚血瘀证疗效及对患者血流状态的影响[J].陕西中医,2021,42(3):338-340.
[8] Louzada RA,Corre R,Ameziane R,et al.Conformation of the N-terminal ectodomain elicits different effects on DUOX function:A potential impact on congenital hypothyroidism caused by a H2O2 production defect[J].Thyroid,2018,28(8):1052-1062.
[9] Zheng X,Ma SG,Guo ML,et al.Compound heterozygous mutations in the DUOX2/DUOXA2 genes cause congenital hypothyroidism[J].Yonsei Med J, 2017,58(4):888-890.
[10] Zhang X,Han J,Feng L,et al.DUOX2 promotes the progression of colorectal cancer cells by regulating the AKT pathway and interacting with RPL3[J].Carcinogenesis, 2021,42(1):105-117.
[11] Burgueno JF,Fritsch J,González EE,et al.Epithelial TLR4 signaling activates DUOX2 to induce microbiota-driven tumorigenesis[J].Gastroenterology,2021,160(3):797-808.
[12] Mestre-Farrera A,Bruch-Oms M,Pena R,et al.Glutamine-directed migration of cancer-activated fibroblasts facilitates epithelial tumor invasion[J].Cancer Res, 2021,81(2):438-451.
[13] Mierke CT.The matrix environmental and cell mechanical properties regulate cell migration and contribute to the invasive phenotype of cancer cells[J].Rep Prog Phys, 2019,82(6):064602.
[14] Cao M,Zhang PB,Wu PF,et al.DUOX2 as a potential prognostic marker which promotes cell motility and proliferation in pancreatic cancer[J].Biomed Res Int,2021,3:6530298.
[15] 刘宇佳,张轶雯,钟里科,等.肿瘤微环境对肿瘤代谢的影响及研究进展[J].肿瘤学杂志,2020,26(1):47-52.
[16] Morotti M,Zois CE,El-Ansari R,et al.Increased expression of glutamine transporter SNAT2/SLC38A2 promotes glutamine dependence and oxidative stress resistance,and is associated with worse prognosis in triple-negative breast cancer[J].Br J Cancer,2021,124(2):494-505.
[17] Deken X,Miot F.DUOX defects and their roles in congenital hypothyroidism[J].Methods Mol Biol,2019,1982:667-693.
[18] 欧阳婷,崔 玮,陈伟恺,等.NOX介导氧化应激与阿尔茨海默病研究进展[J].生命科学,2020,32(12):1338-1345.
[19] Wu D,Dasgupta A,Read AD,et al.Oxygen sensing,mitochondrial biology and experimental therapeutics for pulmonary hypertension and cancer[J].Free Radic Biol Med,2021,170:150-178.
[20] Fu LH,Wan Y,Qi C,et al.Nanocatalytic theranostics with glutathione depletion and enhanced reactive oxygen species generation for efficient cancer therapy[J].Adv Mater, 2021,33(7):2006892.
相似文献/References:
[1]陈正浤,雷光焰△,韩 乐,等.三氧化二砷抑制人肺癌细胞NCI-H460增殖并促进其凋亡实验研究*[J].陕西医学杂志,2020,49(10):1219.[doi:DOI:10.3969/j.issn.1000-7377.2020.10.005]
[2]何建春,李煜华.纵隔型肺癌MRI、CT影像学特征及诊断价值对比研究*[J].陕西医学杂志,2020,49(10):1232.[doi:DOI:10.3969/j.issn.1000-7377.2020.10.008]
HE Jianchun,LI Yuhua..Comparative study on MRI and CT features and diagnostic value for mediastinal lung cancer[J].,2020,49(8):1232.[doi:DOI:10.3969/j.issn.1000-7377.2020.10.008]
[3]荆冠军,赵一鉴△.阿帕替尼治疗晚期肺癌对患者血清肿瘤标志物的影响研究[J].陕西医学杂志,2020,49(10):1351.[doi:DOI:10.3969/j.issn.1000-7377.2020.10.040]
JING Guanjun,ZHAO Yijian..Effect of apatinib on serum tumor markers in patients with advanced lung cancer[J].,2020,49(8):1351.[doi:DOI:10.3969/j.issn.1000-7377.2020.10.040]
[4]张 珊,任小平,田应选.老年肺癌患者心理痛苦现状调查及影响因素分析[J].陕西医学杂志,2021,50(2):245.[doi:DOI:10.3969/j.issn.1000-7377.2021.02.030]
ZHANG Shan,REN Xiaoping,TIAN Yingxuan.Investigation on psychological distress status of elderly patients with lung cancerand analysis of its influencing factors[J].,2021,50(8):245.[doi:DOI:10.3969/j.issn.1000-7377.2021.02.030]
[5]刘振宇,王宏伟.小鼠原位肺癌模型构建及在放射治疗研究中的意义[J].陕西医学杂志,2022,51(7):791.[doi:DOI:10.3969/j.issn.1000-7377.2022.07.005]
LIU Zhenyu,WANG Hongwei.Establishment of mouse model of lung cancer in situ and its significance in study of radiation therapy research[J].,2022,51(8):791.[doi:DOI:10.3969/j.issn.1000-7377.2022.07.005]
[6]代 佳,李 林,贺 林,等.中性粒细胞/淋巴细胞比值、血小板/淋巴细胞比值与肺癌早期诊断以及临床病理特征相关性分析[J].陕西医学杂志,2023,52(4):468.[doi:DOI:10.3969/j.issn.1000-7377.2023.04.024]
[7]王松海,凡 瑾,陈 捷.红景天苷对Lewis 肺癌小鼠恶性胸腔积液的抑制作用及其对免疫功能的影响[J].陕西医学杂志,2024,(1):37.[doi:DOI:10.3969/j.issn.1000-7377.2024.01.008]
WANG Songhai,FAN Jin,CHEN Jie.Inhibitory effect of SALidroside on malignant pleural effusion and its effect on immune function in mice with Lewis lung cancer[J].,2024,(8):37.[doi:DOI:10.3969/j.issn.1000-7377.2024.01.008]
[8]韩海英,郭秀伟,张培彤.川芎对肺癌干细胞原发性肿瘤相关黏附分子影响的实验研究[J].陕西医学杂志,2024,(4):435.[doi:DOI:10.3969/j.issn.1000-7377.2024.04.001]
HAN Haiying,GUO Xiuwei,ZHANG Peitong.Effect of Rhizoma Chuanxiong on primary tumor-associated adhesion molecules of lung cancer stem cells[J].,2024,(8):435.[doi:DOI:10.3969/j.issn.1000-7377.2024.04.001]
[9]管浩然,闫 冰,李骁扬,等.基于4D-CT的三种呼吸门控技术对肺癌立体定向放射治疗计划靶区及正常组织器官体积、受照剂量的影响[J].陕西医学杂志,2024,(7):926.[doi:DOI:10.3969/j.issn.1000-7377.2024.07.013]
GUAN Haoran,YAN Bing,LI Xiaoyang,et al.Effects of three respiratory gating techniques based on 4D-CT on planning target volume and the volume and radiation dose of normal tissues and organs in patients undergoing stereotactic body radiotherapy for lung cancer[J].,2024,(8):926.[doi:DOI:10.3969/j.issn.1000-7377.2024.07.013]
[10]薛 昭,陈 治,张 琴.替莫唑胺联合γ-分次立体定向放疗对肺癌脑转移患者血清骨桥蛋白、细胞角蛋白19片段、鳞状细胞癌抗原水平的影响[J].陕西医学杂志,2025,54(4):492.[doi:DOI:10.3969/j.issn.1000-7377.2025.04.011]
XUE Zhao,CHEN Zhi,ZHANG Qin.Effects of Temozolomide combined with γ-fractionated stereotactic radiotherapy on serum levels of OPN,CYFRA21-1 and SCC in lung cancer patients with brain metastases[J].,2025,54(8):492.[doi:DOI:10.3969/j.issn.1000-7377.2025.04.011]